Navigation Links
New targeted drug helps smokers stub it out
Date:3/17/2011

Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.

Nicotine is absorbed rapidly through the lining of the mouth but most readily through the lungs, from where it quickly passes through the body and into the brain. Once the nicotine reaches the liver, it is metabolised by an enzyme called CYP2A6. Preliminary studies by the Canadian partner of the research project have shown that inhibitors of the nicotine-metabolising CYP2A6 enzyme can help smokers curb the need to smoke. Unfortunately, current CYP2A6 inhibitors are not viable options for anti-smoking therapy, as they involve too many adverse effects.

"We're working on developing a CYP2A6 inhibitor, a targeted drug that would only be effective in specific parts of the body. Thankfully, we have a very clear picture of the structure of CYP2A6, and we'll be able to use computer-aided modelling methods to design molecules that will bind specifically to the target without disturbing other functions in the body. We've now finished our four-year project and have discovered several molecules of an until-now-unknown structure. Along the way, we've gained new insights into how the molecules bind to the active centre of the CYP2A6 enzyme. However, it'll take a good while and money before these molecules can be developed into a targeted drug," says Hannu Raunio, the principal investigator of the research project and Professor of Pharmacology at the University of Eastern Finland.

Traditional anti-smoking therapy has long been focused on smoking cessation. At present, there are a wide variety of treatments available to help smokers quit. Nicotine, buproprion and varenicline are among the most common drugs used in the treatment of smoking addiction. The idea behind pharmaceutical nicotine products is to relieve and prevent withdrawal symptoms so as to pave the way for smoking cessation. However, such forms of treatment are often unsuccessful, which has led to suggestions that new methods are needed, methods that would help in smoking reduction. It is this type of targeted drug that Raunio's project is developing.


'/>"/>

Contact: Professor Hannu Raunio
hannu.raunio@uef.fi
358-405-200-202
Academy of Finland
Source:Eurekalert

Related medicine news :

1. Ohio State study: Targeted ovarian cancer therapy not cost-effective
2. VCU Massey first to combine targeted agents to kill multiple myeloma cells
3. IU Personalized Medicine Institute to develop targeted and individualized treatments
4. Targeted particle fools brains guardian to reach tumors
5. PET scans may allow early prediction of response to targeted therapy of thyroid cancer
6. UMMS and Lundbeck to explore potential targeted therapy for Huntingtons disease
7. Study provides molecular rationale for combining targeted agents to treat breast cancer
8. Protein targeted to stop melanoma tumor growth
9. International clinical trial tests targeted drug for melanoma
10. Targeted breast ultrasound plays key role in evaluating breast abnormalities in women younger than 40
11. Targeted therapy reactivates guardian of the genome in resistant cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Many RNA ... regulatory principles, the research team developed expressRNA, a web platform encompassing computational tools ... reveals at nucleotide resolution the ‘RNA maps’, which demonstrate that RBPs bind to ...
(Date:6/20/2017)... ... 2017 , ... Uniform Advantage (UA), a multi-channel retailer of medical ... create tailored looks and athleisure-inspired outfits. UA Flex fabric is breathable, wrinkle resistant and ... With trendy looks hitting the medical community, UA Flex is for the medical professional ...
(Date:6/20/2017)... ... June 20, 2017 , ... BrightStar Care Centerville/South Dayton, a ... the Joint Commission, which accredits and certifies nearly 21,000 healthcare organizations and programs ... a symbol of quality that reflects an organization’s commitment to meeting certain performance ...
(Date:6/20/2017)... ... 20, 2017 , ... Uniworld Boutique River Cruise Collection recently gave ... boutique ship, S.S. Joie de Vivre . What really sets this ship apart ... River and designed small enough to dock directly in Paris. With The Cruise Web’s ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... BARBARA, Calif. , May 25, 2017  In ... United States , Direct Relief is working with ... overdose-reversing Naloxone available at no cost to community health ... other nonprofit providers nationwide. "Pfizer has ... access to medicines and ensuring patient safety through educational ...
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
(Date:5/18/2017)... WHIPPANY, N.J. , May 17, 2017  Bayer ... growing oncology portfolio will be presented at the 53 ... Clinical Oncology (ASCO), taking place June 2-6 in ... being presented at ASCO span prostate, colorectal, liver and ... subgroup analysis from the Phase II CHRONOS-1 trial of ...
Breaking Medicine Technology: